Israeli-Dutch Innovation Center

Rapid identification of aberrant DNA using Oxford Nanopore Technology sequencers and deep learning algorithms

  • Location Tel Aviv
  • Industry Life sciences and health
  • Online since 2019-12-23

Tel Aviv University is seeking for Dutch partners for validation and commercialization of a rapid identification of aberrant DNA technology using Oxford Nanopore Technology sequencers and deep learning algorithms

Prof Noam Shomron and his team, at the Faculty of Medicine at Tel Aviv University, have developed an assay for rapid segregation between cancer and non-cancer tissues. The samples are passed via Oxford Nanopore Technology sequencers then the data is processed using deep learning algorithms. The academic team is now seeking partners for validation studies, for clinical collaborations, and then for commercialization.

 

Go to website

Maybe you like this as well

  • HTSM: Israel opportunity: 3D printing and beyond conference

    HUJI is organizing a 3D printing conference on the next frontiers: transportation, defense and new metal printing.

    Read more
  • HTSM: Israel Photonics and Electrooptics OASIS7 Conference call for papers

    Call for Papers for the upcoming OASIS 7 Conference - April 1-2, 2019 Tel Aviv

    Read more
  • Health: Israeli Med-tech startup in the field of Obesity and Overweight is looking for Dutch investors

    Melcap system is a dynamic Israeli startup in the medical device and health sector which developed a novel, cost-effective, wireless, ingestible capsu...

    Read more

Get in touch

Do you need some help with extending your network in both The Netherlands or Israel. Connect with us and talk about the possibilities.

  • Israeli-Dutch Innovation Center
    Embassy of the Kingdom of the Netherlands in Israel

  • 14 Abba Hillel Street, Ramat Gan 5250607

  • +972 (0) 52 9530 385

  • racheli@nost.org.il